EDITOR: | March 10th, 2022

Neo Performance Materials Reports Strong Fourth Quarter and Year-End 2021 Results

| March 10, 2022 | No Comments
image_pdfimage_print

Q4 2021 and Full-Year Highlights
(unless otherwise noted, all financial amounts in this news release are expressed in U.S. dollars)

  • Q4 2021 revenue of $153.4 million higher by 39.0% YoY; full-year 2021 revenue of $539.3 million was higher by 55.5% YoY.
  • Volumes in the fourth quarter of 3,311 tonnes; full-year volumes expanded by 20.2%.
  • Operating income of $12.7 million in the quarter; $59.9 million for the year.
  • Adjusted Net Income(1) for the quarter of $16.1 million, or $0.39 per share, with full-year Adjusted Net Income(1) of $55.0 million, or $1.42 per share.
  • Adjusted EBITDA(1) for the quarter of $19.7 million; 2021 Adjusted EBITDA(1) of $81.9 million was 183.7% higher YoY.
  • Cash balance of $89.0 million after raising $38.0 million from equity offering and distributing $12.8 million in dividends to shareholders.
  • A quarterly dividend of Cdn$0.10 per common share was declared on March 9, 2022 for shareholders of record at March 22, 2022, with a payment date of March 30, 2022.

March 10, 2022 (Source) — Neo Performance Materials Inc. (“Neo“, the “Company“) (TSX: NEO) released its 2021 year-end financial results. The financial statements and management’s discussion and analysis (“MD&A“) of these results can be viewed on Neo’s web site at www.neomaterials.com/investors/ and on SEDAR at www.sedar.com.

HIGHLIGHTS OF Q4 2021 AND YEAR-END CONSOLIDATED PERFORMANCE

Neo reported strong year-over-year (“YoY“) gains in revenue, volumes, operating income, Adjusted EBITDA(1), and profitability in the year ended December 31, 2021, driven largely by increased demand for products across all three of its operating divisions, higher selling prices for rare earth materials, and continuing progress in several of the Company’s strategic initiatives.

Consolidated revenue for the year ended December 31, 2021, was $539.3 million compared to $346.7 million for the year ended December 31, 2020; an increase of $192.6 million or 55.5%. Neo reported a net income of $36.0 million, or $0.92 per share, which compared to a net loss of $60.1 million, or $1.54 per share, in 2020.  Adjusted Net Income(1) totaled $55.0 million, or $1.42 per share, which compared to $6.2 million, or $0.16 per share, in 2020. Adjusted EBITDA(1) was $81.9 million, a 183.7% jump over Adjusted EBITDA of $28.9 million in the prior year.

For the three months ended December 31, 2021, consolidated revenue was $153.4 million compared to $110.4 million for the same period in the prior year; an increase of $43.0 million or 39.0%. Neo reported a net income of $7.3 million, or $0.17 per share, which compared to $2.4 million, or $0.06 per share, in the same period of 2020. Adjusted Net Income(1) totaled $16.1 million, or $0.39 per share, which compared to $9.6 million, or $0.25 per share, in the corresponding period of the prior year. Adjusted EBITDA(1) was $19.7 million, a 59.7% jump over Adjusted EBITDA of $12.3 million in the fourth quarter of 2020.

As of December 31, 2021, Neo had cash and cash equivalents of $89.0 million plus restricted cash of $1.3 million, compared to $72.2 million plus $4.2 million as at December 31, 2020. In the year ended December 31, 2021, Neo received $38.0 million of proceeds from issuance of common shares from treasury and distributed $12.8 million in dividends to its shareholders, Neo also entered into two debt agreements for new borrowing capacity in order to raise total cash available to pursue growth opportunities and make investments in working capital. As at December 31, 2021, Neo had approximately $41.5 million available under its credit facilities with $6.5 million drawn, compared to $2.4 million drawn at December 31, 2020.

“The Neo team delivered an outstanding performance in 2021, despite a challenging global landscape,” said Constantine Karayannopoulos, CEO of Neo. “That landscape is even more challenging today with the recent developments in Europe. Our Estonian facility is the only commercial producer of rare earths in Europe and one of only two producers of aerospace-grade tantalum and niobium in the EU and it has not been impacted by the tragic events in Ukraine.  We are working with our advisors to monitor developments closely and we are in close and frequent contact with Estonian government officials, who continue to encourage us to maintain – and expand – our operations there.”

“A key business focus now is meeting the rapidly growing demand for magnetic rare earths in Europe, which are needed by electric vehicles and high-efficiency electric motors. We are partnering with industry and government leaders across Europe with an aim toward helping us establish production in Europe of sintered neo magnets to help meet this demand using rare earth feedstock from North America and elsewhere. Magnetic rare earths and global decarbonization go hand in glove. Neo is committed to helping EuropeNorth America, and other regions respond to rising consumer demand for these sustainable technologies.”

__________________________________

(1) Neo reports non-IFRS measures such as “Adjusted Net Income”, “Adjusted Earnings per Share”, “Adjusted EBITDA”, “Adjusted EBITDA Margin” and “EBITDA”. Please see information on this and other non-IFRS measures in the “Non-IFRS Measures” section of this new release and in the MD&A, available on Neo’s website at www.neomaterials.com and on SEDAR at www.sedar.com.

SELECTED FINANCIAL RESULTS

TABLE 1: Selected Consolidated Results

Year-over-Year Comparison

Quarter-over-Quarter
Comparison

2021

2020

Q4 2021

Q4 2020

Volume (tonnes)

15,103

12,566

3,311

3,683

($000s)

Revenue

539,251

346,692

153,414

110,397

Operating income (loss)

59,887

(55,659)

12,726

3,190

EBITDA(1)

65,431

(40,388)

12,380

4,602

Adjusted EBITDA(1)

81,915

28,874

19,652

12,308

Adjusted EBITDA %(1)

15.2 %

8.3 %

12.8 %

11.1 %

_________________________

(1)Neo reports non-IFRS measures such as “Adjusted Net Income”, “Adjusted Earnings per Share”, “Adjusted EBITDA”, “Adjusted EBITDA Margin” and “EBITDA”. Please see information on this and other non-IFRS measures in the “Non-IFRS Measures” section of this news release and in the MD&A.

For the year ended and three months ended December 31, 2021, revenues of $539.3 million and $153.4 million were 55.5% and 39.0% higher, respectively, than the corresponding periods of 2020. All three segments experienced an increase in revenues as volumes rose due to the economic recovery since the initial impact of COVID-19 in 2020 despite being negatively impacted by the semiconductor chip shortage in the automotive sector and by continuing global supply chain logistics challenges. Selling prices for rare earth products (including Magnequench powders) rose significantly starting from the fourth quarter of 2020 through the fourth quarter of 2021. Rare earth prices remain relatively high compared to more recent historical periods driven primarily by demand for the magnetic elements which are critical in leading technologies such as the electrification of automobiles and other environmentally sustaining technologies. Neo has benefited from these generally higher prices from both a lead-lag perspective (lower cost inventory on hand) and more dollar value margin available generally with higher prices.

MAGNEQUENCH SEGMENT RESULTS

TABLE 2: Selected Magnequench Results

Year-over-Year Comparison

Quarter-over-Quarter
Comparison

2021

2020

Q4 2021

Q4 2020

Volume (tonnes)

6,090

5,016

1,482

1,626

($000s)

Revenue

263,753

152,966

70,897

52,553

Operating income

38,413

20,027

6,608

8,102

EBITDA(1)

49,703

29,726

10,463

10,402

Adjusted EBITDA(1)

48,009

29,928

9,137

11,404

_________________________

(1)Neo reports non-IFRS measures such as “Adjusted Net Income”, “Adjusted Earnings per Share”, “Adjusted EBITDA”, “Adjusted EBITDA Margin” and “EBITDA”. Please see information on this and other non-IFRS measures in the “Non-IFRS Measures” section of this news release and in the MD&A.

For the year ended December 31, 2021, volumes in the Magnequench segment saw a rebound and strong growth compared to prior periods. The year ended December 31, 2020 was significantly impacted by slowdowns and shutdowns in the economy primarily due to impacts from COVID-19. Volumes began to recover in the fourth quarter of 2020 and continued throughout 2021. Despite a tempering of volumes in 2021 due to the pandemic and a slowdown in automotive production due to the global semiconductor chip shortage and the global logistic challenges, sales volumes of Magnequench powders grew by 21% over the prior year and by over 9% compared to the year ended December 31, 2019 (pre-COVID period). In addition, Magnequench compression molded magnet volumes more than doubled over the prior year, continuing the high growth rate achieved since Magnequench began producing and selling compression molded magnets in late 2019.

Magnequench’s focus on key macro growth trend continue to yield positive sales volume growth in areas such as compression magnets and electrified-automotive applications, including traction motors and pumps. Magnequench margins benefited from increased volumes and better absorption of fixed costs as well as the lead-lag impact of prices rising in rare earth components of its powder composition. Although Magnequench has strategically structured most of its sales contracts to contain pass-through pricing provisions for rare earth raw materials, in the year ended and three months ended December 31, 2021, Magnequench benefited significantly from the timing of implementation of these price increases with having some lower cost inventory on hand.

CHEMICALS & OXIDES (“C&O”) SEGMENT RESULTS

TABLE 3: Selected C&O Results

Year-over-Year Comparison

Quarter-over-Quarter
Comparison

2021

2020

Q4 2021

Q4 2020

Volume (tonnes)

8,690

7,348

1,718

2,018

($000s)

Revenue

212,711

143,322

60,389

48,433

Operating income

37,391

(26,505)

10,207

5,124

EBITDA(1)

29,747

(23,134)

7,656

5,065

Adjusted EBITDA(1)

41,512

13,950

11,800

7,103

_________________________

(1)Neo reports non-IFRS measures such as “Adjusted Net Income”, “Adjusted Earnings per Share”, “Adjusted EBITDA”, “Adjusted EBITDA Margin” and “EBITDA”. Please see information on this and other non-IFRS measures in the “Non-IFRS Measures” section of this news release and in the MD&A.

The C&O segment continues to see strong demand for various rare earth products, particularly its magnetic-based products, as the global economy continues to recover from the economic impacts of COVID-19. The demand (and price) for these magnetic elements continues to increase given their use in the electrification of automobiles and other environmentally sustainable technologies. The combination of higher prices and higher demand for magnetic rare earth products resulted in strong financial performance for the C&O segment compared to the prior periods. Higher prices supported higher dollar value margins in C&O’s rare earth separations business in addition to the impact of having lower cost inventory on hand. In C&O’s environmental catalysts business, volumes were reasonably consistent year over year with some slowing in the last quarter of 2021, due to reduced automotive production driven by the semiconductor chip shortage and global logistics challenges. C&O’s environmentally protective water treatment solutions business continues to perform well with higher volume and new customer adoption, although sales volume growth expectations were partially impacted by the challenges in global shipping and logistics availability.

RARE METALS SEGMENT RESULTS

TABLE 4: Selected Rare Metals Results

Year-over-Year Comparison

Quarter-over-Quarter
Comparison

2021

2020

Q4 2021

Q4 2020

Volume (tonnes)

549

412

160

89

($000s)

Revenue

83,604

59,688

27,296

12,096

Operating income (loss)

6,578

(30,006)

2,410

(4,209)

EBITDA(1)

9,415

(28,685)

3,401

(5,323)

Adjusted EBITDA(1)

9,154

(2,189)

3,074

(3,297)

_________________________

(1)Neo reports non-IFRS measures such as “Adjusted Net Income”, “Adjusted Earnings per Share”, “Adjusted EBITDA”, “Adjusted EBITDA Margin” and “EBITDA”. Please see information on this and other non-IFRS measures in the “Non-IFRS Measures” section of this news release and in the MD&A.

Similar to Magnequench and C&O, the prior-year for the Rare Metals segment was also impacted by COVID-19. Throughout the year ended December 31, 2021, the end markets of Rare Metals products exhibited some recovery. The three months ended December 31, 2021, were particularly strong as customers caught up on some historical orders and prices for certain rare metals increased in the quarter with Neo benefiting from having some lower-cost inventory on hand. This benefit offset the losses on other contracts where prices were set prior to the recent price increases causing some lower of cost or net realizable value adjustments for some Rare Metals products.

The improvement in the Rare Metals business in the year ended December 31, 2021 was also attributed to progress made in several key strategic initiatives in the segment, including selling more products outside of the aerospace industry, expanding its customer base, and diversifying its total end-market exposure.  Key progress continues to be made in expanding the capacity of key products (with minimal capital investment) and refocusing the sales pipeline and manufacturing capacity toward more profitable end products. Sales prices in a number of end markets have recovered and gallium-based products are exhibiting improved market demand.

CONFERENCE CALL ON THURSDAY MARCH 10, 2022 AT 10 AM EASTERN

Management will host a teleconference call on Thursday, March 10, 2022 at 10:00 a.m. (Eastern Time) to discuss the fourth quarter 2021 results. Interested parties may access the teleconference by calling (647) 794-4605 (local) or  (866) 575-6539 (toll-free long distance) or by visiting http://cnw.en.mediaroom.com/events. A recording of the teleconference may be accessed by calling (416) 436-0148 (local) or (888) 203-1112 (toll-free long distance), and entering pass code 8108280# until April 10, 2022 or by visiting http://cnw.en.mediaroom.com/events.

NON-IFRS MEASURES

This news release refers to certain non-IFRS financial measures and ratios such as “Adjusted Net Income”, “EBITDA”, “Adjusted EBITDA”, and “Adjusted EBITDA Margin”. These measures and ratios are not recognized measures under IFRS, do not have a standardized meaning prescribed by IFRS, and may not be comparable to similar measures presented by other companies. Rather, these measures and ratios are provided as additional information to complement IFRS financial measures by providing further understanding of Neo’s results of operations from management’s perspective. Neo’s definitions of non-IFRS measures used in this news release may not be the same as the definitions for such measures used by other companies in their reporting. Non-IFRS measures and ratios have limitations as analytical tools and should not be considered in isolation nor as a substitute for analysis of Neo’s financial information reported under IFRS. Neo uses non-IFRS financial measures and ratios to provide investors with supplemental measures of its base-line operating performance and to eliminate items that have less bearing on operating performance or operating conditions and thus highlight trends in its core business that may not otherwise be apparent when relying solely on IFRS financial measures. Neo believes that securities analysts, investors and other interested parties frequently use non-IFRS financial measures and ratios in the evaluation of issuers. Neo’s management also uses non-IFRS financial measures in order to facilitate operating performance comparisons from period to period. For definitions of how Neo defines such financial measures and ratios, please see the “Non-IFRS Financial Measures” section of Neo’s management’s discussion and analysis filing for the year ended December 31, 2021, available on Neo’s web site at www.neomaterials.com and on SEDAR at www.sedar.com.

TABLE 5: CONSOLIDATED STATEMENTS OF FINANCIAL POSITION

($000s)

December 31, 2021

December 31, 2020

ASSETS

Current

Cash and cash equivalents

$

89,037

$

72,224

Restricted cash

1,283

4,219

Accounts receivable

65,209

51,851

Inventories

200,954

130,867

Income taxes receivable

1,667

2,186

Assets held for sale

415

Other current assets

19,211

13,889

Total current assets

377,361

275,651

Property, plant and equipment

73,378

74,322

Intangible assets

49,961

53,653

Goodwill

70,082

68,967

Investments

13,759

10,045

Deferred tax assets

6,638

3,040

Other non-current assets

2,903

864

Total non-current assets

216,721

210,891

Total assets

$

594,082

$

486,542

LIABILITIES AND EQUITY

Current

Bank advances and other short-term debt

$

6,502

$

2,428

Accounts payable and other accrued charges

94,201

79,106

Income taxes payable

7,059

2,945

Provisions

5,560

2,628

Lease obligations

1,589

1,297

Derivative liability

14,704

9,428

Other current liabilities

1,455

940

Total current liabilities

131,070

98,772

Employee benefits

1,210

2,358

Provisions

15,127

4,201

Deferred tax liabilities

13,366

13,970

Lease obligations

1,388

2,243

Other non-current liabilities

1,405

1,513

Total non-current liabilities

32,496

24,285

Total liabilities

163,566

123,057

Non-controlling interest

2,891

1,490

Equity attributable to equity holders of Neo Performance Materials Inc

427,625

361,995

Total equity

430,516

363,485

Total liabilities and equity

$

594,082

$

486,542

____________________________

See accompanying notes to this table in Neo’s Consolidated Financial Statements for the Year Ended December 31, 2021, available on Neo’s website at www.neomaterials.com and on SEDAR at www.sedar.com.

TABLE 6: CONSOLIDATED RESULTS OF OPERATIONS

Comparison of the year ended and three months ended December 31, 2021 to the year ended and three months ended December 31, 2020:

($000s)

Year Ended December
31,

Three Months Ended
December 31,

2021

2020

2021

2020

Revenue

$

539,251

$

346,692

$

153,414

$

110,397

Costs of sales

Costs excluding depreciation and amortization

380,548

256,928

111,718

82,104

Depreciation and amortization

8,176

9,430

2,405

1,999

Gross profit

150,527

80,334

39,291

26,294

Expenses

Selling, general and administrative

58,445

53,702

17,421

16,113

Share-based compensation

4,526

1,733

1,765

817

Depreciation and amortization

7,689

7,750

1,891

1,899

Research and development

19,859

13,724

5,367

4,275

Impairment of assets

121

59,084

121

90,640

135,993

26,565

23,104

Operating income (loss)

59,887

(55,659)

12,726

3,190

Other expense

(9,750)

(2,318)

(4,351)

(2,253)

Finance (cost) income, net

(3,943)

(878)

(1,523)

2,484

Foreign exchange loss

(4,388)

(651)

(2,544)

(211)

Income (loss) from operations before income taxes
and equity income of associates

41,806

(59,506)

4,308

3,210

Income tax (expense) benefit

(9,580)

(1,643)

702

(832)

Income (loss) from operations before equity income
of associates

32,226

(61,149)

5,010

2,378

Equity income (loss) of associates (net of income tax)

3,817

1,060

2,253

(22)

Net income (loss)

$

36,043

$

(60,089)

$

7,263

$

2,356

Attributable to:

Equity holders of Neo

$

35,177

$

(57,931)

$

6,735

$

2,219

Non-controlling interest

866

(2,158)

528

137

$

36,043

$

(60,089)

$

7,263

$

2,356

Earnings (Loss) per share attributable to equity
holders of Neo:

Basic

$

0.92

$

(1.54)

$

0.17

$

0.06

Diluted

$

0.91

$

(1.54)

$

0.17

$

0.06

____________________________

See Management’s Discussion and Analysis for the Year Ended December 31, 2021, available on Neo’s website at www.neomaterials.com and on SEDAR at www.sedar.com.

TABLE 7: RECONCILIATION OF NET INCOME (LOSS) TO EBITDA, ADJUSTED EBITDA AND FREE CASH FLOW

($000s)

Year Ended December 31,

Three Months Ended
December 31,

2021

2020

2021

2020

Net income (loss)

$

36,043

$

(60,089)

$

7,263

$

2,356

Add back (deduct):

Finance cost (income), net

3,943

878

1,523

(2,484)

Income tax expense (benefit)

9,580

1,643

(702)

832

Depreciation and amortization included in costs of sales

8,176

9,430

2,405

1,999

Depreciation and amortization included in operating expenses

7,689

7,750

1,891

1,899

EBITDA

65,431

(40,388)

12,380

4,602

Adjustments to EBITDA:

Other expense  (1)

9,750

2,318

4,351

2,253

Foreign exchange loss (2)

4,388

651

2,544

211

Equity income of associates

(3,817)

(1,060)

(2,253)

22

Share and value-based compensation (3)

4,526

4,244

1,765

3,584

Impairment of assets (4)

121

59,084

121

Other costs (5)

1,516

4,025

744

1,636

Adjusted EBITDA (6)

$

81,915

$

28,874

$

19,652

$

12,308

Adjusted EBITDA Margins (6)

15.2%

8.3%

12.8%

11.1%

Less:

Capital expenditures

$

9,464

$

7,614

2,833

1,178

Free Cash Flow (6)

$

72,451

$

21,260

16,819

11,130

Free Cash Flow Conversion (6)

88.4%

73.6%

85.6%

90.4%

Notes:

(1)

Represents other expenses resulting from non-operational related activities, including provisions for estimated damages for outstanding legal claims related to historic volumes, costs for disposal of historically generated NORM and fair value remeasurement of equity securities. These costs and recoveries are not indicative of Neo’s ongoing activities. 

(2)

Represents unrealized and realized foreign exchange losses (gains) that include non-cash adjustments in translating foreign denominated monetary assets and liabilities.

(3)

Represents share and value-based compensation expense in respect of the Plan, the Legacy Plan, the LTIP and the long-term value bonus plan. The long-term value bonus plan is included in selling and administration expense and has similar vesting criteria to the share-based plan and is settled in cash for non-executives and non-North Americans where implementation of a share settlement plan would have been prohibitively expensive in terms of administration and compliance. For the year ended and three months ended December 31, 2021, value-based compensation expense was nil, as the financial statement impact of the liquidity event was recorded in the year ended December 31, 2020. For the year ended and three months ended December 31, 2020, value-based compensation recovery was $2,511 and $2,767, respectively. Neo has removed both the share and value-based compensation expense from EBITDA to provide comparability with historic periods and to treat it consistently with the share-based awards that they are intended to replace.

(4)

The negative economic impacts of COVID-19 were determined to be an impairment indicator as of June 30, 2020 for all Neo’s CGUs. In accordance with IAS 36 Impairment of Assets, the recoverable amount of Neo’s CGUs was determined based on fair value less cost of disposal for the Magnequench segment and value in use for the C&O and the Rare Metals segments. As a result of the impairment test, Neo recognized an impairment charge of $59.1 million as of June 30, 2020, with $35.1 million attributable to the C&O segment and $24.0 million attributable to the Rare Metals segment. No impairment was recorded against the Magnequench segment.

(5)

These represent primarily legal, professional advisory fees and other transaction costs incurred with respect to non-operating capital structure related transactions and restructuring costs related to management team changes. Neo has removed these charges to provide comparability with historic periods.

(6)

Neo reports non-IFRS measures such as “Adjusted Net Income”, “Adjusted Earnings per Share”, “Adjusted EBITDA”, “Adjusted EBITDA Margin”, “Free Cash Flow” and “Free Cash Flow Conversion”. Please see information on this and other non-IFRS measures in the “Non-IFRS Measures” section of this new release and in the MD&A, available on Neo’s website www.neomaterials.com and on SEDAR at www.sedar.com

TABLE 8: RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED NET INCOME (LOSS)

($000s)

Year Ended December
31,

Three Months Ended
December 31,

2021

2020

2021

2020

Net income (loss)

$

36,043

$

(60,089)

$

7,263

$

2,356

Adjustments to net income (loss):

Foreign exchange loss (1)

4,388

651

2,544

211

Impairment of assets (2)

121

59,084

121

Share and value-based compensation (3)

4,526

4,244

1,765

3,584

Other costs (4)

1,516

4,025

744

1,636

Other items included in other  expense (5)

10,681

2,136

4,519

2,136

Tax impact of the above items

(2,235)

(3,886)

(894)

(340)

Adjusted net income (6)

$

55,040

$

6,165

$

16,062

$

9,583

Attributable to:

Equity holders of Neo

$

54,174

$

6,056

$

15,534

$

9,446

Non-controlling interest

$

866

$

109

$

528

$

137

Weighted average number of common shares outstanding:

Basic

38,140,110

37,629,963

39,332,282

37,505,596

Diluted

38,543,348

37,629,963

39,841,690

38,211,305

Adjusted earnings (loss) per share (6) attributable to equity holders of Neo:

Basic

$

1.42

$

0.16

$

0.39

$

0.25

Diluted

$

1.41

$

0.16

$

0.39

$

0.25

Notes:

(1)

Represents unrealized and realized foreign exchange losses (gains) that include non-cash adjustments in translating foreign denominated monetary assets and liabilities.

(2)

The negative economic impacts of COVID-19 were determined to be an impairment indicator as of June 30, 2020 for all Neo’s CGUs. In accordance with IAS 36 Impairment of Assets, the recoverable amount of Neo’s CGUs was determined based on fair value less cost of disposal for the Magnequench segment and value in use for the C&O and the Rare Metals segments. As a result of the impairment test, Neo recognized an impairment charge of $59.1 million as of June 30, 2020, with $35.1 million attributable to the C&O segment and $24.0 million attributable to the Rare Metals segment. No impairment was recorded against the Magnequench segment.

(3)

Represents share and value-based compensation expense in respect of the Plan, the Legacy Plan, the LTIP and the long-term value bonus plan. The long-term value bonus plan is included in selling and administration expense and has similar vesting criteria to the share-based plan and is settled in cash for non-executives and non-North Americans where implementation of a share settlement plan would have been prohibitively expensive in terms of administration and compliance. For the year ended and three months ended December 31, 2021, value-based compensation expense was nil, as the financial statement impact of the liquidity event was recorded in the year ended December 31, 2020. For the year ended and three months ended December 31, 2020, value-based compensation recovery was $2,511 and $2,767, respectively. Neo has removed both the share and value-based compensation expense from net income to provide comparability with historic periods and to treat it consistently with the share-based awards that they are intended to replace.

(4)

These represent primarily legal, professional advisory fees and other transaction costs incurred with respect to non-operating capital structure related transactions and restructuring costs related to management team changes. Neo has removed these charges to provide comparability with historic periods.

(5)

Represents other expenses resulting from non-operational related activities, including provisions for estimated damages for outstanding legal claims related to historic volumes, and costs for disposal of historically generated NORM. These costs and recoveries are not indicative of Neo’s ongoing activities.

(6)

Neo reports non-IFRS measures such as “Adjusted Net Income”, “Adjusted Earnings per Share”, “Adjusted EBITDA”, “Adjusted EBITDA Margin”, “Free Cash Flow” and “Free Cash Flow Conversion”. Please see information on this and other non-IFRS measures in the “Non-IFRS Measures” section of this new release and in the MD&A, available on Neo’s website www.neomaterials.com and on SEDAR at www.sedar.com.

About Neo Performance Materials

Neo manufactures the building blocks of many modern technologies that enhance efficiency and sustainability. Neo’s advanced industrial materials – magnetic powders and magnets, specialty chemicals, metals, and alloys – are critical to the performance of many everyday products and emerging technologies. Neo’s products help to deliver the technologies of tomorrow to consumers today. The business of Neo is organized along three segments: Magnequench, Chemicals & Oxides and Rare Metals. Neo is headquartered in Toronto, Ontario, Canada; with corporate offices in Greenwood Village, Colorado, US; Singapore; and Beijing, China. Neo operates globally with sales and production across 10 countries, being JapanChinaThailandEstoniaSingaporeGermanyUnited KingdomCanadaUnited States, and South Korea. For more information, please visit www.neomaterials.com.

Cautionary Statements Regarding Forward Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws in Canada. Forward-looking information may relate to future events or future performance of Neo. All statements in this release, other than statements of historical facts, with respect to Neo’s objectives and goals, as well as statements with respect to its beliefs, plans, objectives, expectations, anticipations, estimates, and intentions, are forward-looking information. Specific forward-looking statements in this discussion include, but are not limited to, the following: expectations regarding certain of Neo’s future results and information, including, among other things, revenue, expenses, sales growth, capital expenditures, and operations; statements with respect to current and future market trends that may directly or indirectly impact sales and revenue of Neo; expected use of cash balances; continuation of prudent management of working capital; source of funds for ongoing business requirements and capital investments; expectations regarding sufficiency of the allowance for uncollectible accounts and inventory provisions; analysis regarding sensitivity of the business to changes in exchange rates; impact of recently adopted accounting pronouncements; risk factors relating to intellectual property protection and intellectual property litigation; risk factors relating to national or international economies (including the impact of COVID-19), and other risks present in the jurisdictions in which Neo, its customers, its suppliers, and/or its logistics partners operate, and; expectations concerning any remediation efforts to Neo’s design of its internal controls over financial reporting and disclosure controls and procedures. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “continues”, “forecasts”, “projects”, “predicts”, “intends”, “anticipates” or “believes”, or variations of, or the negatives of, such words and phrases, or state that certain actions, events or results “may”, “could”, “would”, “should”, “might” or “will” be taken, occur or be achieved. This information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. Neo believes the expectations reflected in such forward-looking information are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information included in this discussion and analysis should not be unduly relied upon. For more information on Neo, investors should review Neo’s continuous disclosure filings that are available under Neo’s profile at www.sedar.com.

SOURCE Neo Performance Materials, Inc.

For further information: Ali Mahdavi, SVP, Corporate Development & Capital Markets, (416) 962-3300, Email: a.mahdavi@neomaterials.com; Jim Sims, Director of Corporate Communications, (303) 503-6203, Email: j.sims@neomaterials.com; Website: www.neomaterials.com; Email: info@neomaterials.com


Editor:

InvestorIntel.com is a leading online source of investor information that provides public market coverage for both investors and industry alike. A qualified online influencer through ... <Read more about InvestorIntel>


Copyright © 2022 InvestorIntel Corp. All rights reserved. More & Disclaimer »


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.